Inpharmatica Makes Good on its Discovery Plans, Commits to Stay in Data Business | GenomeWeb

Almost exactly a year after revealing its plans to move toward drug discovery [BioInform 07-09-01], London-based Inpharmatica has cemented its commitment with the launch of a new informatics-driven platform that it intends to use for its own discovery activities as well as in research collaborations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.